Literature DB >> 28122325

Demographic, clinical and pathological features of sudden deaths due to myocarditis: Results from a state-wide population-based autopsy study.

Liliang Li1, Yang Zhang2, Allen Burke2, Aimin Xue3, Ziqin Zhao3, David Fowler4, Yiwen Shen5, Ling Li6.   

Abstract

Causes of sudden cardiac deaths have been widely reported with limited data focused specifically on myocarditis. A retrospective review of cases from the Office of the Chief Medical Examiner (OCME), State of Maryland yielded a total of 103 sudden unexpected deaths (SUDs) due to myocarditis (0.17% of all SUDs and 0.70% of autopsied SUDs) from 2005 through 2014. Most deaths occurred in patients <30 years of age with a male:female ratio 1.3:1. Of the 103 cases, 45 (43.7%) patients were witnessed collapsed. Four deaths occurred during exertion, such as exercising at the gym or performing heavy physical work, and 2 deaths were associated with emotional stress. The common cardiac macroscopic findings included ventricular dilatation (39.8%), mild coronary stenosis (17.5%), mottled myocardial appearance (15.5%), and myocardial fibrosis (10.7%). The histological classification of myocarditis was based on the predominant type of inflammatory cell infiltration. In our study group, lymphocytic myocarditis was most common, accounting for 56 cases (54.4%), followed by neutrophilic (32 cases, 31.7%), eosinophilic (13 cases, 12.6%) and giant cell type (2 cases, 1.9%). Microscopic examination revealed myocyte necrosis in 69 cases (67.0%) and interstitial or perivascular fibrosis in 48 cases (46.6%). The percentage of myocyte necrosis was 75.0% (42/58 cases) in lymphocytic, 65.6% (21/31 cases) in neutrophilic, 30.8% (4/13 cases) in eosinophilic, and 100% (2/2 cases) in giant cell myocarditis. Determination of myocarditis as cause of death continues to present a major challenge to forensic pathologists, because histopathologic findings can be subtle and the diagnosis of myocarditis remains difficult.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Certainty of diagnosis; Dilated cardiomyopathy; Myocarditis; Sudden deaths

Mesh:

Year:  2017        PMID: 28122325     DOI: 10.1016/j.forsciint.2016.12.037

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  6 in total

1.  Computational Identification of Ventricular Arrhythmia Risk in Pediatric Myocarditis.

Authors:  Mark J Cartoski; Plamen P Nikolov; Adityo Prakosa; Patrick M Boyle; Philip J Spevak; Natalia A Trayanova
Journal:  Pediatr Cardiol       Date:  2019-03-06       Impact factor: 1.655

2.  Fast spontaneous recovery from acute necrotizing eosinophilic myopericarditis without need for immunosuppressive therapy: a case report of a 27-year-old male.

Authors:  Michael Kindermann; Nitin Sood; Peter Ehrlich; Karin Klingel
Journal:  Eur Heart J Case Rep       Date:  2020-06-17

3.  The histopathological spectrum of myocardial inflammation in relation to circumstance of death: a retrospective cohort study in clinical and forensic autopsies.

Authors:  Romy du Long; Judith Fronczek; Hans W M Niessen; Allard C van der Wal; Hans H de Boer
Journal:  Forensic Sci Res       Date:  2021-11-25

4.  Impact of ventricular arrhythmias on outcomes in children with myocarditis.

Authors:  Hasan F Othman; Jonathan Byrnes; Esraa Elsamny; Mohammed Hamzah
Journal:  Eur J Pediatr       Date:  2020-05-23       Impact factor: 3.183

5.  Sudden cardiac death caused by myocarditis in persons aged 1-49 years: a nationwide study of 14 294 deaths in Denmark.

Authors:  Thomas Hadberg Lynge; Trine Skov Nielsen; Bo Gregers Winkel; Jacob Tfelt-Hansen; Jytte Banner
Journal:  Forensic Sci Res       Date:  2019-08-19

6.  Global, Regional, and National Burden of Myocarditis From 1990 to 2017: A Systematic Analysis Based on the Global Burden of Disease Study 2017.

Authors:  Xiqiang Wang; Xiang Bu; Linyan Wei; Jing Liu; Dandan Yang; Douglas L Mann; Aiqun Ma; Tomohiro Hayashi
Journal:  Front Cardiovasc Med       Date:  2021-07-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.